Cell reprogramming: much promise, many hurdles
A picture released by Kyoto University on October 5 shows a mouse (right which was born from an egg cell made from induced pluripotent stem (iPS) cells of a mouse, and this mouse's offspring. Japanese stem cell researchers announced they had created viable eggs using normal cells from an adult body on October 5.
Research in reprogrammed cells, which on Monday earned the 2012 Nobel Prize, has been hailed as a new dawn for regenerative medicine but remains troubled by several clouds.
Britain's John Gurdon and Japan's Shinya Yamanaka were honoured with the world's paramount award in medicine for induced pluripotent stem cells (iPSCs).
They discovered that a mature, adult cell can be turned back to an infant, versatile state called a stem cell.
First theorised in the late 19th century, stem cells are touted as a source of replacement tissue, fixing almost anything from malfunctioning hearts and lungs, damaged spines, Parkinson's disease or even baldness.
The first human trials were launched only in 2010, and progress has been dogged by the contested use of stem cells taken from early-stage embryos, where the most adaptable, or pluripotent, cells are found.
Created by Yamanaka in 2006, iPSCs ease the moral row as they derive from adult cells and not embryos, said University of Oxford ethics professor Julian Savulescu.
Ordinary skin cells can be used as the starting material.
"Many people objected to the creation of embryos for research, describing it as cannabalizing human beings," he said.
George W. Bush "retarded the field for years" by blocking US government funds for human embryonic stem cell research, a decision reversed in 2009 by President Barack Obama, he added.
Last year, Europe's top court banned patents of stem cells when their extraction caused the destruction of a human embryo—a decision lamented by scientists but hailed by Catholic bishops.
After many years in the lab, stem cells are now cautiously being tested on humans.
A combination of two recent pictures shows, at left, John Gurdon of Britain and at right Shinya Yamanaka of Japan, who both won the Nobel Prize on October 8, 2012 for work in cell programming. Research in reprogrammed cells has been hailed as a new dawn for regenerative medicine but remains troubled by several clouds.In 2010, US biotech firm ACT began the first stem cell trial in the world on patients with retinal disease that causes blindness.
Last year, doctors in the United States gave 16 heart attack victims an infusion of cardiac stem cells, restoring vitality in heart muscle and blood-pumping ability.
In Sweden, a 36-year-old man was given an artificial windpipe, which used a synthetic "scaffold" covered with his own stem cells.
But none of these and other small-scale stem cell trials involve iPSCs.
Researchers freely admit that this fledgling technology has many unknowns—and all must be resolved before tests can proceed on human volunteers.
One early shock was that, among lab mice, iPSCs developed into tumours, a problem traced to a reprogramming gene and the retroviruses used to generate the cells.
To create an iPSC, "we have to genetically modify [the adult cell] by introducing at least three different genes," said Paul Fairchild, director of the Oxford Stem Cell Institute.
"It is that process of genetic modification which can risk transforming the cell, and making it cancerous. That is where the safety concerns lie."
A colony of human embryonic stem cells is seen on a computer monitor hooked up to a microscope at the Wisconsin National Primate Research Center in 2009. Research in reprogrammed cells, which on Monday earned the 2012 Nobel Prize, has been hailed as a new dawn for regenerative medicine but remains troubled by several clouds.One argument in favour of iPSCs is that because they are derived from one's own DNA, they will be accepted by the immune defences as friends and thus be spared from attack.
But last year a study found that certain kinds of iPSCs may be rejected by the immune system.
"The assumption that cells derived from iPSCs are totally immune-tolerant has to be re-evaluated before considering human trials," warned Yang Xu, a professor of biology at the University of California at San Diego.
In February, a team led by Joseph Ecker of the Salk Institute for Biological Studies in California found that the transformation from adult cell to stem cell can be incomplete.
DNA errors pop up in an area of the genome called the epigenome, which is the switching system that turns genes on or off and determines their level of activity.
"Lots of people are working on getting over the roadblocks," said Fairchild, adding, with optimism: "It is only a matter of time."
(c) 2012 AFP
- Induced pluripotent stem cells at risk for rejection May 13, 2011 | not rated yet | 0
- Discovery of reprogramming signature may help further stem cell-based regenerative medicine research Sep 19, 2012 | not rated yet | 0
- Rethinking reprogramming: A new way to make stem cells Apr 07, 2011 | not rated yet | 0
- Adult stem cells take root in livers and repair damage May 11, 2011 | not rated yet | 0
- Researchers discover key molecule for stem cell pluripotency May 27, 2011 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
Pressure-volume curve: Elastic Recoil Pressure don't make sense
12 hours ago From pressure-volume curve of the lung and chest wall (attached photo), I don't understand why would the elastic recoil pressure of the lung is...
If you became brain-dead, would you want them to pull the plug?
May 17, 2013 I'd want the rest of me to stay alive. Sure it's a lousy way to live but it beats being all-the-way dead. Maybe if I make it 20 years they'll...
MRI bill question
May 15, 2013 Dear PFers, The hospital gave us a $12k bill for one MRI (head with contrast). The people I talked to at the hospital tell me that they do not...
Ratio of Hydrogen of Oxygen in Dessicated Animal Protein
May 13, 2013 As an experiment, for the past few months I've been consuming at least one portion of Jell-O or unflavored Knox gelatin per day. I'm 64, in very...
Alcohol and acetaminophen
May 13, 2013 Edit: sorry for the typo in the title , can't edit I looked around on google quite a bit and it's very hard to find precise information on the...
Marie Curie's leukemia
May 13, 2013 Does anyone know what might be the cause of Marie Curie's cancer
- More from Physics Forums - Medical Sciences
More news stories
In 2008 researchers from the University of Southern Denmark showed that the drug thioridazine, which has previously been used to treat schizophrenia, is also a powerful weapon against antibiotic-resistant bacteria such as ...
Medical research 23 hours ago | 3.7 / 5 (3) | 0 |
Scientists investigating the interaction of a group of proteins in the brain responsible for protecting nerve cells from damage have identified a new target that could increase cell survival.
Medical research May 17, 2013 | 5 / 5 (1) | 0
New findings by researchers carrying out experiments at the U.S. Department of Energy Office of Science's Advanced Photon Source (APS) help explain why some drugs that interact with two kinds of human serotonin ...
Medical research May 17, 2013 | not rated yet | 0 |
Peptide molecules derived from the body's natural immune system can help boost the body's defence against life-threatening blood poisoning, joint University research has uncovered.
Medical research May 17, 2013 | 4 / 5 (1) | 0 |
A new Montréal study conducted by Dr. May Faraj, associate research professor at the Université de Montréal and invited scientist at the IRCM, along with her research team and medical collaborators, shows ...
Medical research May 17, 2013 | not rated yet | 0 |
An increasing number of U.S. children are experiencing gastrointestinal issues that require interventions to resolve, according to research presented at Digestive Disease Week (DDW).
5 hours ago | not rated yet | 0 |
The latest makeover to a massive psychiatric tome honored by some, reviled by others and even called the "Bible" of mental disorders is being released Saturday with a host of new changes.
3 hours ago | not rated yet | 0
A new case of the deadly coronavirus has been detected in Saudi Arabia where 15 people have already died after contracting it, the health ministry announced on Saturday on its Internet website.
3 hours ago | not rated yet | 0
Big names in medicine are set to give an upbeat assessment of the war on AIDS on Tuesday, 30 years after French researchers identified the virus that causes the disease.
13 hours ago | 5 / 5 (1) | 0
For combat veterans suffering from post-traumatic stress disorder, 'fear circuitry' in the brain never rests
Chronic trauma can inflict lasting damage to brain regions associated with fear and anxiety. Previous imaging studies of people with post-traumatic stress disorder, or PTSD, have shown that these brain regions can over-or ...
14 hours ago | 5 / 5 (1) | 0 |
A ground-breaking advance in colonoscopy technology signals the future of colorectal care, according to research presented today at Digestive Disease Week(DDW). Additional research focuses on optimizing the minimal withdrawal ...
5 hours ago | 5 / 5 (1) | 0